With the European Medicines Agency giving the green light for the use of Pfizer/BioNTech’s vaccine in 12-15 year-olds (see EUROPE B12729A19), the European Centre for Disease Prevention and Control (ECDC) published a report on Tuesday 1 June aimed at helping European public health authorities make decisions on the use of this vaccine in adolescents.
The report identifies three “potential objectives” to be considered: protecting the health of adolescents, “normalising” their lives...